Tezspire is a medicine used to treat: * severe asthma in adults and adolescents (12 years of age and older). It is used as an additional treatment in adults and adolescents with severe asthma that is not adequately controlled by a combination of high\-dose corticosteroids taken by inhalation plus another asthma medicine; * severe chronic (long\-term) rhinosinusitis with nasal polyps (inflamed lining of the nose and sinuses with growths in the nose) in adults. Tezspire is used with a corticosteroid given into the nose when treatment with a corticosteroid given by mouth or injection and/or surgery, does not work well enough. Tezspire contains the active substance tezepelumab.
Therapeutic Indication
Asthma Tezspire is indicated as an add\-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment. Chronic rhinosinusitis with nasal polyps (CRSwNP) Tezspire is indicated as an add\-on therapy with intranasal corticosteroids for the treatment of adult patients with severe CRSwNP for whom therapy with systemic corticosteroids, and/or surgery do not provide adequate disease control.
Therapeutic Area (MeSH)
ATC Code
R03DX11
ATC Item
N/A
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
EMA Name
Tezspire
Medicine Name
Tezspire
Aliases
N/ANo risk management plan link.
